All data are based on the daily closing price as of March 28, 2025
l

L&C Bio

290650.KQ
14.99 USD
0.01
+0.07%

Overview

Last close
14.99 usd
Market cap
340.14M usd
52 week high
26.63 usd
52 week low
10.84 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
7.1264
Price/Book Value
3.478
Enterprise Value
377.73M usd
EV/Revenue
7.9281
EV/EBITDA
7.864

Key financials

Revenue TTM
49.01M usd
Gross Profit TTM
18.36M usd
EBITDA TTM
8.81M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
190.90M usd
Net debt
N/A usd

About

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    290650.KQ
  • Exchange
    KQ
  • Isin
    KR7290650001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Mr. Chul Lee Whan
  • Headquarter
    Seongnam-si
  • Web site
    https://www.lncbio.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top